Abstract
Preimplantation Genetic Testing for Monogenic Conditions (PGT-M) is increasingly becoming an important reproductive option for individuals and couples planning a pregnancy. In Australia, government funding for PGT-M came into effect in November 2021 and has improved accessibility for families with an increased chance of having a child with a single gene condition. Demand for PGT-M is expected to grow as genetic screening and testing become more widely utilised. In particular, the acceptability of PGT-M as a reproductive option for adult-onset conditions has led to increasing uptake compared to prenatal diagnosis. As indications for the use of PGT-M increase, there is increased complexity and ethical decision-making to balance the autonomy of individuals and the resulting offspring. Genetic counselling is integral in helping families make informed choices about whether to undergo PGT-M, and if so, how their testing strategy will be individualised to their individual needs. This presentation will use case studies to discuss the counselling and ethical considerations when offering PGT-M.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
